These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
705 related articles for article (PubMed ID: 25832448)
1. Osteoporosis: the evolution of a diagnosis. Lorentzon M; Cummings SR J Intern Med; 2015 Jun; 277(6):650-61. PubMed ID: 25832448 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. Schousboe JT; Taylor BC; Fink HA; Kane RL; Cummings SR; Orwoll ES; Melton LJ; Bauer DC; Ensrud KE JAMA; 2007 Aug; 298(6):629-37. PubMed ID: 17684185 [TBL] [Abstract][Full Text] [Related]
3. Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Ettinger MP Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222 [TBL] [Abstract][Full Text] [Related]
4. Health-economic comparison of three recommended drugs for the treatment of osteoporosis. Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171 [TBL] [Abstract][Full Text] [Related]
5. Fighting the fracture cascade: evaluation and management of osteoporotic fractures. Sack F Postgrad Med; 2008 Nov; 120(4):51-7. PubMed ID: 19020365 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology, etiology, and diagnosis of osteoporosis. Lane NE Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873 [TBL] [Abstract][Full Text] [Related]
8. Effect of alendronate on bone mineral density in Puerto Rican males with osteoporosis. Martinó A; Rosa J; Guzmán J; Ramírez M P R Health Sci J; 2005 Jun; 24(2):131-5. PubMed ID: 16116930 [TBL] [Abstract][Full Text] [Related]
9. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis. Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260 [TBL] [Abstract][Full Text] [Related]
10. Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. Vanasse A; Dagenais P; Niyonsenga T; Grégoire JP; Courteau J; Hemiari A BMC Musculoskelet Disord; 2005 Jun; 6():33. PubMed ID: 15969760 [TBL] [Abstract][Full Text] [Related]
11. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond. Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322 [TBL] [Abstract][Full Text] [Related]
16. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231 [TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of osteoporotic fractures. Gardner MJ; Demetrakopoulos D; Shindle MK; Griffith MH; Lane JM Minerva Med; 2005 Oct; 96(5):343-52. PubMed ID: 16227949 [TBL] [Abstract][Full Text] [Related]
18. Osteoporosis: a still increasing prevalence. Reginster JY; Burlet N Bone; 2006 Feb; 38(2 Suppl 1):S4-9. PubMed ID: 16455317 [TBL] [Abstract][Full Text] [Related]
19. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment]. Nishida A; Ito M Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605 [TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and vertebral fractures in men. Legrand E; Chappard D; Pascaretti C; Duquenne M; Rondeau C; Simon Y; Rohmer V; Basle MF; Audran M Osteoporos Int; 1999; 10(4):265-70. PubMed ID: 10692973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]